Supplementary Figure S6 from Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells
Abstract
Supplementary Figure S6, related to Figure 4. PARP7i and AHRa response biomarker offers predictive benefits over some, though not all, markers of immune infiltration.
Fields of Study & Subjects
PARP inhibition in cancer therapy
Endoplasmic Reticulum Stress and Disease
Nuclear Receptors and Signaling
Publication details
- Publication date
- 2 January 2026